Immune recovery in breast cancer patients after tandem high-dose chemotherapy rescued by selected CD34+ cells [3]

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 6, 2002, Pages 991-994

  Lalle, Maurizio ^a,b,d   De Rosa, Luca ^b   Pandolfi, Annino ^b   Amodeo, Rachele ^b   De Blasio, Angelo ^c   Montuoro, Aldo ^b   Marzetti, Luigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Divisione di Ematologia   (Italy)

^c SANTA MARIA GORETTI HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN;

ADULT; APHERESIS; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL TRANSPLANTATION; DRUG EFFICACY; DRUG MEGADOSE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; LETTER; PRIORITY JOURNAL; STEM CELL; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; GRAFT SURVIVAL; HEMATOPOIESIS; HUMANS; IMMUNE SYSTEM; LYMPHOCYTE COUNT; LYMPHOCYTES; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036966297     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581602321080673     Document Type: Letter

References (10)

1. Deisseroth AB, Z Zu, D Claxton, EG Hanania, S Fu, D Ellerson, L Goldberg, M Thomas, K Janicek, WF Anderson, J Hester, M Korbling, A Durett, R Moen, R Berenson, S Heimfeld, J Hamer, L Calvert, P Tibbits, M Talpaz, H Kantarjian, R Champlin and C Reading. (1994). Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation in CML. Blood 83:3068-3076.
2. Rill DR, VM Santana, WM Roberts, T Nilson, LC Bowman, RA Krance, HE Helsop, RC Moen, JN Ihle and MK Brenner. (1994). Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383.
3. Hakim FT, R Cepeda, S Kaimei, CL Mackall, N Mcatee, JA Zujewski, K Cowan and RE Gress. (1997). Constraints on CD4 recovery post chemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:3789-3798.
4. + T-lymphocyte regeneration after intensive chemotherapy, New Engl J Med 332:143-149.
5. Roberts MM, LB To, D Gillis, J Mundy, C Rawling, K Ng and CA Juttner. (1993). Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 12:469-475.
6. + hematopoietic progenitors. Blood 91:2588-2600.
7. Nachbaur D, G Kropshofer, H Feitctinger, F Allerbeger and D Niederwieser. (1997). Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation. Treatment with paromomycin, azithromycin and recombinant interleukin-2. Bone Marrow Transplant 19:1261-1263.
8. Holmberg LA, M Boeckh, H Hooper, W Leisenring, S Rowley, S Heimfeld, O Press, DG Maloney, P McSweeney, L Corey, RT Maziarz, FR Appelbaum and W Bensinger. (1999). Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 94:4029-4035.
9. + enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation. Bone Marrow Transplant 26:831-836,
10. Muller-Hermelink HK, GE Sale, B Borisch and R Storb. (1987). Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. Am J Pathol 29:242-256.